Wednesday, 14 Nov 2018

Bangla Version

New blood test can spare cancer patients chemotherapy

No icon Spot Light

Health Desk: 18th Oct’18: A simple new blood test being trialled across 40 hospitals in Australia and New Zealand could spare cancer patients from having to undergo unnecessary chemotherapy.

Developed by the Walter and Eliza Hall Institute of Medical Research (WEHI) in Melbourne, the test is able to determine if fragments of tumour DNA are present in a patient's blood after they've had tumours surgically removed.

At present, there is no clear way to tell if a tumour has been entirely removed or not, so patients after surgery are given chemotherapy treatment a precautionary measure.

But as well as sparing patients from a wide range of harmful side effects which include pain, fatigue, nausea, digestive issues, bleeding problems, fertility issues, increased susceptibility to infection, heart, lung, nerve and memory problems, the test will may also be able to detect if a patient requires an increased dose of chemotherapy.

Courtesy: Xinhua